Scholarlink

Background <p>Abnormal connections between the trachea and esophagus, known as tracheoesophageal fistula (TEFs) and bronchoesophageal fistula (BEFs), are uncommon but potentially life-threatening conditions that can result in severe complications. This study aimed to explore the anatomical features, underlying causes of TEF and BEF and evaluate the treatment efficacy.</p> Methods <p>This retrospective study reviewed 15 cases of TEF/BEF treated at the University Hospital from 2001 to 2020. It examines the anatomical features, underlying causes, and treatment outcomes of these fistulas and evaluates various treatment modalities, such as open surgery, tracheal and esophageal stenting, and gastrostomy/jejunostomy.</p> Results <p>This study included 15 patients (aged 15–65 years). Most cases were non-malignant (80%), mainly due to post-intubation injuries, while 20% were associated with malignancies, such as lymphoma and esophageal cancer. The fistulas were mostly located in the mid-trachea, with 40% measuring 1–3&#xa0;cm. Gastrostomy/jejunostomy is the most common treatment option, particularly in malignant cases. The morbidity rate was 46.7%, with tracheal stenosis being the most frequent complication and no deaths reported. Follow-up (1–23 months) showed significant improvement in benign TEFs but no improvement in malignant TEFs.</p> Conclusion <p>This study highlights the challenges in managing TEF/BEF and advocates treatment plans tailored to the specific etiology and characteristics of the fistula. These findings contribute to the limited existing literature on acquired TEF/BEF, suggesting that a multidisciplinary approach is essential for optimizing patient outcomes in these complex cases.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical insights and management outcomes of tracheoesophageal and bronchoesophageal fistulas: a 20-year case series review

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月17日

查看全文
  • Salem Algomaa Alhadid,
  • Sakhr Alshwayyat,
  • Hamdah Hanifa,
  • Noor Almasri,
  • Zaid Taimeh,
  • Mustafa Alshwayyat,
  • Tala Abdulsalam Alshwayyat,
  • Alhareth M. Amro,
  • Bassam Darwish

摘要

Background

Abnormal connections between the trachea and esophagus, known as tracheoesophageal fistula (TEFs) and bronchoesophageal fistula (BEFs), are uncommon but potentially life-threatening conditions that can result in severe complications. This study aimed to explore the anatomical features, underlying causes of TEF and BEF and evaluate the treatment efficacy.

Methods

This retrospective study reviewed 15 cases of TEF/BEF treated at the University Hospital from 2001 to 2020. It examines the anatomical features, underlying causes, and treatment outcomes of these fistulas and evaluates various treatment modalities, such as open surgery, tracheal and esophageal stenting, and gastrostomy/jejunostomy.

Results

This study included 15 patients (aged 15–65 years). Most cases were non-malignant (80%), mainly due to post-intubation injuries, while 20% were associated with malignancies, such as lymphoma and esophageal cancer. The fistulas were mostly located in the mid-trachea, with 40% measuring 1–3 cm. Gastrostomy/jejunostomy is the most common treatment option, particularly in malignant cases. The morbidity rate was 46.7%, with tracheal stenosis being the most frequent complication and no deaths reported. Follow-up (1–23 months) showed significant improvement in benign TEFs but no improvement in malignant TEFs.

Conclusion

This study highlights the challenges in managing TEF/BEF and advocates treatment plans tailored to the specific etiology and characteristics of the fistula. These findings contribute to the limited existing literature on acquired TEF/BEF, suggesting that a multidisciplinary approach is essential for optimizing patient outcomes in these complex cases.